Report

Download as pdf or txt
Download as pdf or txt
You are on page 1of 4

Patient Name : Mr.

RAJANIKANTA NAYAK Collected : 24/Jul/2023 09:47AM


Age/Gender : 29 Y 7 M 30 D /M Received : 24/Jul/2023 12:41PM
UHID/MR No : APJ1.0018675540 Reported : 24/Jul/2023 02:52PM
Visit ID : DOCLOPV676 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : JHARPADA,Bhubaneswar

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method

GLUCOSE, FASTING , SODIUM FLUORIDE 266 mg/dL 70-100 GOD - POD


PLASMA

Comment:
As per American Diabetes Guidelines
Fasting Glucose Values in mg/d L Interpretation
<100 mg/dL Normal
100-125 mg/dL Prediabetes
≥126 mg/dL Diabetes

HBA1C, GLYCATED HEMOGLOBIN , 10.7 % HPLC


WHOLE BLOOD EDTA
ESTIMATED AVERAGE GLUCOSE (eAG) , 260 mg/dL Calculated
WHOLE BLOOD EDTA

Comment:
Reference Range as per American Diabetes Association (ADA):
REFERENCE GROUP HBA1C IN %
NON DIABETIC ADULTS >18 YEARS <5.7
AT RISK (PREDIABETES) 5.7 – 6.4
DIAGNOSING DIABETES ≥ 6.5
DIABETICS
·         EXCELLENT CONTROL 6 – 7
·         FAIR TO GOOD CONTROL 7 – 8
·         UNSATISFACTORY CONTROL 8 – 10
·         POOR CONTROL >10
Note: Dietary preparation or fasting is not required.

1. A1C test should be performed at least two times a year in patients who are meeting treatment goals (and who have stable
glycemic control).
2. Lowering A1C to below or around 7% has been shown to reduce microvascular and neuropathic complications of type 1
and type 2 diabetes. When mean annual HbA1c is <1.1 times ULN (upper limit of normal), renal and retinal complications
are rare, but complications occur in >70% of cases when HbA1c is >1.7 times ULN.
3. Falsely low HbA1c (below 4%) may be observed in patients with clinical conditions that shorten erythrocyte life span or
Page 1 of 4
Patient Name : Mr.RAJANIKANTA NAYAK Collected : 24/Jul/2023 09:47AM
Age/Gender : 29 Y 7 M 30 D /M Received : 24/Jul/2023 12:41PM
UHID/MR No : APJ1.0018675540 Reported : 24/Jul/2023 02:52PM
Visit ID : DOCLOPV676 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : JHARPADA,Bhubaneswar

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method

decrease mean erythrocyte age. HbA1c may not accurately reflect glycemic control when clinical conditions that affect
erythrocyte survival are present. Fructosamine may be used as an alternate measurement of glycemic control

Page 2 of 4
Patient Name : Mr.RAJANIKANTA NAYAK Collected : 24/Jul/2023 09:47AM
Age/Gender : 29 Y 7 M 30 D /M Received : 24/Jul/2023 12:41PM
UHID/MR No : APJ1.0018675540 Reported : 24/Jul/2023 02:52PM
Visit ID : DOCLOPV676 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : JHARPADA,Bhubaneswar

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method

*** End Of Report ***

Page 3 of 4
Patient Name : Mr.RAJANIKANTA NAYAK Collected : 24/Jul/2023 09:47AM
Age/Gender : 29 Y 7 M 30 D /M Received : 24/Jul/2023 12:41PM
UHID/MR No : APJ1.0018675540 Reported : 24/Jul/2023 02:52PM
Visit ID : DOCLOPV676 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Patient location : JHARPADA,Bhubaneswar

DEPARTMENT OF BIOCHEMISTRY
Test Name Result Unit Bio. Ref. Range Method

Page 4 of 4

SIN No:BI15264337,BI15264336

You might also like